Investigation of the Effect of BI 1815368 on the Pharmacokinetics of Metformin Following Multiple Oral Administration in Healthy Subjects (an Open-label, Randomised, Two-way Crossover Trial)
Latest Information Update: 28 Oct 2024
At a glance
- Drugs BI 1815368 (Primary) ; Metformin
- Indications Unspecified
- Focus Pharmacokinetics
- Sponsors Boehringer Ingelheim
- 28 Oct 2024 New trial record